Compare Enbridge Inc (ENB) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs 10X Genomics Inc — how do they compare? Enbridge Inc trades at $51.8 (market cap $112.62B), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: Enbridge Inc is far larger — about 14.8× 10X Genomics Inc's market cap, and Enbridge Inc pays a 5.34% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ENB | TXG | |
|---|---|---|
Market Cap | $112.62B | $7.61B |
Sector | Energy | Health |
52-Week High | $58.04 | $58.57 |
52-Week Low | $45.23 | $11.34 |
Enterprise Value | $196.53B | $7.14B |
Dividend Yield | 5.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
